Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes

Nature Medicine

Volumn 15, Issue 8, 2009, Pages 967-973

  Edgington, Laura E ^a   Berger, Alicia B ^a   Blum, Galia ^a,b   Albrow, Victoria E ^a   Paulick, Margot G ^a   Lineberry, Neil ^a   Bogyo, Matthew ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CATHEPSIN; DEXAMETHASONE; FLUORESCENT DYE; MONOCLONAL ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE; IMAGING; IN VIVO STUDY; MOLECULAR PROBE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMUS;

ANIMALS; APOPTOSIS; CASPASES; DEXAMETHASONE; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; ENZYME ACTIVATION; FLUORESCENT DYES; HUMANS; MICE; MICE, NUDE; MODELS, BIOLOGICAL; NEOPLASMS; OPTICAL PHENOMENA; THYMUS GLAND; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 68349148319     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.1938     Document Type: Article

References (35)

1. Ntziachristos, V. et al. Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc. Natl. Acad. Sci. USA 101, 12294-12299 (2004).
2. Petrovsky, A., Schellenberger, E., Josephson, L., Weissleder, R. & Bogdanov, A. Jr. Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res. 63, 1936-1942 (2003).
3. Schellenberger, E.A. et al. Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy. Neoplasia 5, 187-192 (2003).
4. Blankenberg, F.G., Vanderheyden, J.L., Strauss, H.W. & Tait, J.F. Radiolabeling of HYNIC-annexin V with technetium-99m for in vivo imaging of apoptosis. Nat. Protoc. 1, 108-110 (2006).
5. Belhocine, T. et al. Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin. Cancer Res. 8, 2766-2774 (2002).
6. Rottey, S., Siegers, G., Van Belle, S., Goethals, I. & Van de Wiele, C. Sequential 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy. J. Nucl. Med. 47, 1813-1818 (2006).
7. Vermeersch, H. et al. 99mTc-HYNIC Annexin-V imaging of primary head and neck carcinoma. Nucl. Med. Commun. 25, 259-263 (2004).
8. Hofstra, L. et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 356, 209-212 (2000).
9. Aloya, R. et al. Molecular imaging of cell death in vivo by a novel small molecule probe. Apoptosis 11, 2089-2101 (2006).
10. Cohen, A. et al. From the Gla domain to a novel small-molecule detector of apoptosis. Cell Res. 19, 625-637 (2009).
11. Laxman, B. et al. Noninvasive real-time imaging of apoptosis. Proc. Natl. Acad. Sci. USA 199, 16551-16555 (2002).
12. Bullok, K. & Piwnica-Worms, D. Synthesis and characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. J. Med. Chem. 48, 5404-5407 (2005).
13. Bauer, C., Bauder-Wuest, U., Mier, W., Haberkorn, U. & Eisenhut, M. 1311-labeled peptides as caspase substrates for apoptosis imaging. J. Nucl. Med. 46, 1066-1074 (2005).
14. Thornberry, N.A. et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272, 17907-17911 (1997).
15. Kato, D. et al. Activity-based probes that target diverse cysteine protease families. Nat. Chem. Biol. 1, 33-38 (2005).
16. Sexton, K.B., Witte, M.D., Blum, G. & Bogyo, M. Design of cell-permeable, fluorescent activity-based probes for the lysosomal cysteine protease asparaginyl endopeptidase (AEP)/legumain. Bioorg. Med. Chem. Lett. 17, 649-653 (2007).
17. Zhou, D. et al. Synthesis, radiolabeling and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis. Bioorg. Med. Chem. Lett. 16, 5041-5046 (2006).
18. Bedner, E., Smolewski, P., Amstad, P. & Darzynkiewicz, Z. Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation. Exp. Cell Res. 259, 308-313 (2000).
19. Smolewski, P. et al. Detection of caspases activation by fluorochrome-labeled inhibitors: multiparameter analysis by laser scanning cytometry. Cytometry 44, 73-82 (2001).
20. Méthot, N. et al. A caspase active site probe reveals high fractional inhibition needed to block DNA fragmentation. J. Biol. Chem. 279, 27905-27914 (2004).
21. Pozarowski, P. et al. Interactions of fluorochrome-labeled caspase inhibitors with apoptotic cells: a caution in data interpretation. Cytometry A 55, 50-60 (2003).
22. Rozman-Pungerčar, J. et al. Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity. Cell Death Differ. 10, 881-888 (2003).
23. Berger, A.B. et al. Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes. Mol. Cell 23, 509-521 (2006).
24. Felsher, D.W. & Bishop, J.M. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell 4, 199-207 (1999).
25. Richard, J.P. et al. Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J. Biol. Chem. 280, 15300-15306 (2005).
26. Cohen, J.J. Glucocorticoid-induced apoptosis in the thymus. Semin. Immunol. 4, 363-369 (1992).
27. Odaka, C. & Mizuochi, T. Macrophages are involved in DNA degradation of apoptotic cells in murine thymus after administration of hydrocortisone. Cell Death Differ. 9, 104-112 (2002).
28. Brewer, J.A., Kanagawa, O., Sleckman, B.P. & Muglia, L.J. Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo. J. Immunol. 169, 1837-1843 (2002).
29. 123l]annexin V and in situ oligonucleotide ligation. J. Mol. Histol. 38, 313-319 (2007).
30. Adams, C. et al. Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5. Cell Death Differ. 15, 751-761 (2008).
31. Ashkenazi, A. Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev. 19, 325-331 (2008).
32. Vivès, E., Brodin, P. & Lebleu, B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017 (1997).
33. Sexton, K.B. et al. Specificity of aza-peptide electrophile activity-based probes of caspases. Cell Death Differ. 14, 727-732 (2007).
34. Lee, A. & Ellman, J.A. Parallel solution-phase synthesis of mechanism-based cysteine protease inhibitors. Org. Lett. 3, 3707-3709 (2001).
35. Blum, G., von Degenfeld, G., Merchant, M.J., Blau, H.M. & Bogyo, M. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. Nat. Chem. Biol. 3, 668-677 (2007).